Skip to main content
Caplight Logo









PopVax

PopVax

Private
HyderabadHealthcare & Life Scienceshttps://popvax.com/

Last Round

Grant

Sep 1, 2025

Total Funding Raised

$35.85M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

PopVax is a biotechnology company that develops mRNA vaccines and therapeutics using machine learning-driven computational protein design.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI

Business Model

B2G

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

mRNA vaccinelipid nanoparticleLNPbiotechdrug discoverygenerative AIprotein designAI-powered drug discoveryCDMOcontract manufacturingcancer immunotherapythermostable vaccinebiologicsvaccine platformin silico design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PopVax Comparables

Compare PopVax with similar companies based on industry and business-model similarity.

PopVax comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Providence Therapeutics
85%
Abogen Biosciences
78%
Innovac Therapeutics
76%

PopVax Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2025
GrantJan 13, 2025
GrantOct 29, 2024
GrantAug 1, 2023

PopVax Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 114% MoM, reaching 16.1K.

  • Apr 24, 2026

    Grew 16% QoQ, from 70 to 81 employees.

PopVax Filings

Explore SEC and related filing metadata, where available.

PopVax filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PopVax's valuation, stock price, and market status.

Is PopVax a public or private company?

PopVax is a private company.

What is the current stock price of PopVax?

PopVax is a private company with no public stock price. No recent secondary market data is available.

How much is PopVax worth (valuation)?

Valuation information for PopVax is not publicly available.

Can I buy PopVax stock?

PopVax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PopVax's last funding round?

PopVax's most recent funding round was Grant on September 1, 2025.

Who are the main investors in PopVax?

Key investors in PopVax include Good Ventures.

Will PopVax IPO soon?

No public IPO plans have been announced for PopVax.

How can I track PopVax secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PopVax's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHyderabad
Employee Range73
Year Founded2021
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?